Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Peptides from rice endosperm protein restrain periodontal bone loss in mouse model of periodontitis.

Tamura H, Maekawa T, Domon H, Hiyoshi T, Yonezawa D, Nagai K, Ochiai A, Taniguchi M, Tabeta K, Maeda T, Terao Y.

Arch Oral Biol. 2019 Feb;98:132-139. doi: 10.1016/j.archoralbio.2018.11.021. Epub 2018 Nov 20.

PMID:
30485826
2.

Immunization with pneumococcal elongation factor Tu enhances serotype-independent protection against Streptococcus pneumoniae infection.

Nagai K, Domon H, Maekawa T, Hiyoshi T, Tamura H, Yonezawa D, Habuka R, Saitoh A, Terao Y.

Vaccine. 2019 Jan 3;37(1):160-168. doi: 10.1016/j.vaccine.2018.11.015. Epub 2018 Nov 13.

PMID:
30442480
3.

Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis clinical isolates from children with acute otitis media in Japan from 2014 to 2017.

Nagai K, Kimura O, Domon H, Maekawa T, Yonezawa D, Terao Y.

J Infect Chemother. 2019 Mar;25(3):229-232. doi: 10.1016/j.jiac.2018.08.018. Epub 2018 Sep 29.

PMID:
30279114
4.

Mechanism of Macrolide-Induced Inhibition of Pneumolysin Release Involves Impairment of Autolysin Release in Macrolide-Resistant Streptococcus pneumoniae.

Domon H, Maekawa T, Yonezawa D, Nagai K, Oda M, Yanagihara K, Terao Y.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e00161-18. doi: 10.1128/AAC.00161-18. Print 2018 Nov.

PMID:
30181369
5.

Neutrophil Elastase Subverts the Immune Response by Cleaving Toll-Like Receptors and Cytokines in Pneumococcal Pneumonia.

Domon H, Nagai K, Maekawa T, Oda M, Yonezawa D, Takeda W, Hiyoshi T, Tamura H, Yamaguchi M, Kawabata S, Terao Y.

Front Immunol. 2018 Apr 25;9:732. doi: 10.3389/fimmu.2018.00732. eCollection 2018.

6.

Pneumococcal DNA-binding proteins released through autolysis induce the production of proinflammatory cytokines via toll-like receptor 4.

Nagai K, Domon H, Maekawa T, Oda M, Hiyoshi T, Tamura H, Yonezawa D, Arai Y, Yokoji M, Tabeta K, Habuka R, Saitoh A, Yamaguchi M, Kawabata S, Terao Y.

Cell Immunol. 2018 Mar;325:14-22. doi: 10.1016/j.cellimm.2018.01.006. Epub 2018 Jan 16.

PMID:
29366563
7.

Bone Healing at Functionally Loaded and Unloaded Screw-Shaped Implants Supporting Single Crowns: A Histomorphometric Study in Humans.

Yonezawa D, Piattelli A, Favero R, Ferri M, Iezzi G, Botticelli D.

Int J Oral Maxillofac Implants. 2018 Jan/Feb;33(1):181-187. doi: 10.11607/jomi.5928.

PMID:
29340352
8.

Elevated antibody titers to Porphyromonas gingivalis as a possible predictor of ischemic vascular disease - results from the Tokamachi-Nakasato cohort study.

Tabeta K, Tanabe N, Yonezawa D, Miyashita H, Maekawa T, Takahashi N, Okui T, Nakajima T, Yamazaki K.

J Atheroscler Thromb. 2011;18(9):808-17. Epub 2011 Jun 13.

9.

Porphyromonas gingivalis antigens and interleukin-6 stimulate the production of monocyte chemoattractant protein-1 via the upregulation of early growth response-1 transcription in human coronary artery endothelial cells.

Maekawa T, Takahashi N, Honda T, Yonezawa D, Miyashita H, Okui T, Tabeta K, Yamazaki K.

J Vasc Res. 2010;47(4):346-54. doi: 10.1159/000265568. Epub 2009 Dec 16.

10.

Rhodanese, but not cystathionine-gamma-lyase, is associated with dextran sulfate sodium-evoked colitis in mice: a sign of impaired colonic sulfide detoxification?

Taniguchi E, Matsunami M, Kimura T, Yonezawa D, Ishiki T, Sekiguchi F, Nishikawa H, Maeda Y, Ishikura H, Kawabata A.

Toxicology. 2009 Oct 1;264(1-2):96-103. doi: 10.1016/j.tox.2009.07.018. Epub 2009 Jul 30.

PMID:
19647029
11.

Construction of arginine-rich peptide displaying bionanocapsules.

Shishido T, Yonezawa D, Iwata K, Tanaka T, Ogino C, Fukuda H, Kondo A.

Bioorg Med Chem Lett. 2009 Mar 1;19(5):1473-6. doi: 10.1016/j.bmcl.2009.01.049. Epub 2009 Jan 22.

PMID:
19200722
12.

A protective role of hydrogen sulfide against oxidative stress in rat gastric mucosal epithelium.

Yonezawa D, Sekiguchi F, Miyamoto M, Taniguchi E, Honjo M, Masuko T, Nishikawa H, Kawabata A.

Toxicology. 2007 Nov 20;241(1-2):11-8. Epub 2007 Aug 6.

PMID:
17825973
13.

Mechanisms for modulation of mouse gastrointestinal motility by proteinase-activated receptor (PAR)-1 and -2 in vitro.

Sekiguchi F, Hasegawa N, Inoshita K, Yonezawa D, Inoi N, Kanke T, Saito N, Kawabata A.

Life Sci. 2006 Jan 25;78(9):950-7. Epub 2005 Sep 26.

PMID:
16188279
14.

2-Furoyl-LIGRL-NH2, a potent agonist for proteinase-activated receptor-2, as a gastric mucosal cytoprotective agent in mice.

Kawabata A, Oono Y, Yonezawa D, Hiramatsu K, Inoi N, Sekiguchi F, Honjo M, Hirofuchi M, Kanke T, Ishiwata H.

Br J Pharmacol. 2005 Jan;144(2):212-9.

15.

Potent and metabolically stable agonists for protease-activated receptor-2: evaluation of activity in multiple assay systems in vitro and in vivo.

Kawabata A, Kanke T, Yonezawa D, Ishiki T, Saka M, Kabeya M, Sekiguchi F, Kubo S, Kuroda R, Iwaki M, Katsura K, Plevin R.

J Pharmacol Exp Ther. 2004 Jun;309(3):1098-107. Epub 2004 Feb 19.

PMID:
14976227

Supplemental Content

Loading ...
Support Center